| Radiopharmaceutical | Administered Activity | Effective Dose | |
|---|---|---|---|
| MBq | mCi | cSv | |
| In-111 IgG | 75 | 2 | 1.5 |
| Tc-99m IgG | 370 | 10 | 0.3 |
| In-111 WBCs | 25 | 0.7 | 1.5 |
| Tc-99m WBCs | 370 | 10 | 0.6 |
| Ga-67 citrate | 220 | 6 | 2.7 |
| Tc99m Leutech | 370-740 | 5-10 | TBA |
| Tc-99m WBC | Tc-99m Leutech | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N = 58 | N = 49 | ||||||||||||||||||
|
|
||||||||||||||||||
| Sens = 100%
Spec = 74% |
Sens = 100%
Spec = 83% |
||||||||||||||||||
| t(positive) = 72 min
t(nuke->Sx) = 6.8 h |
t(positive) = 42 min
t(nuke->Sx) = 5.5 h |
| N = 200 (including prior table)
123F / 79M 5-86 y |
|||||||||
|
|||||||||
| Sens = 90%
Spec = 87% |
|||||||||
| t < 30 min for 84% of poitives |